Serratia marcescens serotypes 06:K14, 08:K14 and 028:K28 are common in the natural environment, but rare in hospitals. Serotypes 014:K14 and 027:K14 predominate among clinical strains, but not in the environment, suggesting that the latter serotypes may be more suited for survival in the clinical setting. Consequently, 469 epidemiologically distinct strains of S. marcescens were tested for various putative virulence factors and analysed for associations with serotype. The factors positively associated with serotype 014:K14 were agglutination of five different species of red blood cells and expression of type 1 fimbriae. These were found in 63% and 53% of 014:K14 strains, respectively, compared with 7% and 12% of the three 'environmental serotypes'. Almost a quarter of the collection expressed the mannose-resistant haemagglutinin indicative of type 3 fimbriae, but this was not associated with any serotype. The production of DNAase, haemolysin, lipase, lecithinase, proteases and siderophores was almost universal and showed no serotype correlations. Almost half of the strains (46%) were resistant to serum and serotypes 027:K14 and 06:K14 were strongly associated with this characteristic. Serotype 027:K14 was also associated with higher proportions of antibiotic-resistant strains than other serotypes, but the same was not true of serotype 014:K14. All three 'environmental serotypes' were associated with low frequencies of antibiotic resistance; < 12Y0 were resistant to gentamicin, carbenicillin or piperacillin, or any combination of these three, compared with 20-25% of 014:K14 strains and > 42-51% of 027:K14 strains. Pigment production was strongly associated with serotype. None of the 014:K14 or 027:K14 strains produced prodigiosin, but frequencies for the three 'environmental serotypes' ranged from 31 YO of 028:K28 strains to 85% of 06:K14 strains. The results of this study suggest that the adherence capability of S. marcescens strains may play a role in the colonisation of hospital patients, while the production of prodigiosin is a marker of environmental origin.
Introduction
The gram-negative bacillus Serratia marcescens is not normally considered highly pathogenic for man because it rarely causes primary infections. However, it is a cause for concern in hospitals, because as an opportunistic pathogen, it can be responsible for serious infections and occasional fatalities in compromised patients. Such infections often occur in clusters and their epidemiology can be investigated by typing techniques [I] . Serotyping is a well-established method in which differences in the chemistry of bacterial cell surface structures are detected with panels of antisera. Most schemes are based on either the 0 antigens of lipopolysaccharide (LPS) or the K antigens of capsular polysaccharide. Recently, new 0 and K typing schemes have been described for this species [2] , and applied to a collection of both clinical and environmental S. rnarcescens isolates selected to represent distinct strains [3] . The latter study showed a marked difference in serotype distribution between the two populations. Serotypes common in the natural environment were rare in hospitals and vice versa. In particular, the 014:K14 serotype accounted for almost a third of clinical strains, but only 5% of the environmental collection. This would suggest that some kind of selection process occurs in the transfer of strains fiom the non-clinical environment to hospitals. The aim of the current investigation was to determine whether virulence factors such as haemagglutination as a measure of adhesion, extracellular enzyme production, serum resistance and antibiotic resistance, could account for the apparent prevalence of 014:K14 strains over those of other serotypes.
Materials and methods

Bacterial strains
The collection of 423 distinct clinical strains was selected as described previously [ 31. It included isolates from 77 hospitals representing 46 different towns and cities, 29 of which were in England. Four Welsh or Scottish hospitals were represented as well as eight hospitals in six other European countries; these 12 hospitals accounted for 93 isolates. Twenty isolates were from four non-European countries: Oman, India, Australia and New Zealand.
In addition, 46 environmental strains were available for this study: 29 strains from insects, plants and rodents were received as a gift from Drs I? and F.
Grimont, Institut Pasteur, Paris, France; 17 strains were obtained from the National Collection of Type Cultures or were submitted to this laboratory for identification or epidemiological typing.
All strains were maintained on nutrient agar or glycerol agar [4] and stored at -20°C on 2-mm glass beads in glycerol broth 20% w/v.
Serotype identij'ication
0 and K serotypes were identified by ELISA with adsorbed antisera [2] and the frequency distributions were reported in a separate study [3] .
Haemagglutination
Chicken (CPHL), guinea-pig (CPHL), horse (TCS Biologicals, Botolph Claydon), cynomolgus monkey (Shamrock Great Britain, Brighton), human A positive and 0 positive (CPHL), rabbit (CPHL), rat (CPHL) and goat (TCS) blood were supplied either in Alsever's solution or with sodium citrate 0.4 %/3 ml blood as an anti-coagulant. The red blood cells (RBC) were washed three times in phosphate-buffered saline (PBS) at 400 g for 10 min and resuspended in PBS at a concentration of 50%. Tanned human group A cells were prepared by adding 10 ml of sterile-filtered tannic acid 0.005% in saline to 10 ml of 2.5% washed cells in PBS [5] . After 10 min at 37"C, the cells were centrifuged, washed once and resuspended in PBS as above.
A 3% suspension of RBC was prepared by adding 0.5 ml RBC 50% to either PBS or PBS +mannose 0.5%. Bacterial suspensions were prepared from overnight growth at 37°C from colonisation factor agar [6] containing bile salts (Oxoid, Unipath, Basingstoke) 0.15%. The growth was covered with PBS and left at room temperature for c. 1 h to detach from the agar. After gentle resuspension, 50-pl drops of cell suspensions were placed on a dimpled perspex tray by row, and equal drops of the RBC 3% suspensions were added by column. After rocking on ice for 1 min, the trays were left on ice for a further 10 min and rocked again before the haemagglutination was recorded as negative, weakly positive or strongly positive.
Tests with and without mannose were performed simultaneously. Agglutination of equal degree of strength in the absence or presence of mannose was reported as mannose-resistant haemagglutination (MR-HA), while mannose-sensitive haemagglutinat ion (MS-HA) was completely abolished by mannose. If the presence of mannose resulted in only partial inhibition of haemagglutination, the strain was considered to exhibit both mannose-sensitive and mannose-resistant activity. The presence of MS-HA of guinea-pig RBC and of MR-HA tanned human A-positive cells (MRK-HA) were considered indicative of type 1 and type 3 fimbriae, respectively [7] .
Extracellular products
DNA-toluidine blue agar plates, Tlveen 80 agar plates, nutrient gelatin stabs, Columbia agar plates (Oxoid) with horse blood 940, and skimmed milk powder casein plates were used for the detection of DNAase, lipase, gelatinase, haemolysin and caseinase respectively [ 81. Lecithinase activity was assessed with lecithovitellin agar plates, prepared by adding 50ml of egg yolk emulsion (Oxoid) to 500 ml of molten nutrient agar at 55°C. Siderophore production was detected with Schwyn and Neilands' universal siderophore agar [ 
91.
For each test strain, 20 pl of an overnight, 37°C tryptone soya broth culture were diluted in 2 ml of sterile distilled water to c. lo7 cells/ml and 25 pl of this were inoculated on to the agar media and incubated at 30°C. Results were recorded as the radius of the reaction halo on days 1, 2 and 5. DNAase changed the colour of the agar from blue to pink; lipase and lecithinase activity resulted in an opaque or opalescent halo; gelati nase liquefied agar stabs; haemolysin and caseinase produced zones of clearing; and siderophores produced a yellowing of the blue-green agar. Reproducibility studies with 18 strains showed that the variation of zone radii was within 3 mm of the original.
Serum resistance
Normal human serum (NHS) was prepared from clotted blood samples from four laboratory volunteers and stored at -70°C in 0.5-ml aliquots for up to 1 month. An overnight, 37°C tryptone soya broth culture was used to prepare a suspension of c. lo7 cells/ml by dilution of 10 pl in 1 ml of Hanks's Balanced Salts Solution (HBSS). For the assay, 50 p l of this suspension were added to an equal volume of either HBSS (control wells) or NHS (test wells) in rigid, polystyrene microtitration trays (Bibby Sterilin, Stone, Staffs). After incubation at 37°C for 3 h, the plates were shaken for c. 1 min, and three 20-pl drops from each well were spotted on nutrient agar plates. These were incubated at 30°C overnight and the growth was scored as confluent, semi-confluent, >50 discrete colonies, or as the number of discrete colonies if < 50. The test and control wells were prepared in duplicate and repeated if discrepant results were observed. Three control strains (resistant, intermediately sensitive and highly sensitive) were included in each batch of tests. The serumresistant control strain produced confluent growth and the highly sensitive strain < 120 cells/ml (usually none at all). Viable counts of the intermediately sensitive strain varied from 120 to 5000 cells/ml and these values were used to define strains as either highly sensitive, intermediately sensitive or resistant.
Antibiotic resistance
The minimum inhibitory concentrations (MIC) of the 14 antibiotics listed in Table 2 for the collection of strains were determined by an agar dilution method [ 101. Briefly, bacteria were grown on nutrient agar and five colonies were resuspended in 5 ml of IsoSensitest broth to produce a suspension of c. lo6 cells/ml. After 4 h at 37OC, 0.03-pl volumes containing 104-105 bacteria were spotted on IsoSensitest agar supplemented with lysed horse blood 2% and the appropriate antibiotic, with a multipoint inoculator. The plates were incubated for 18-24 h at 37°C and the growth was recorded with the aid of a Mastascan image analyser (Mast Diagnostics, Merseyside). The MIC of an antibiotic for each strain was taken as that concentration for which there was 'no visible growth, disregarding one or two colonies or hazes of uninhibited growth' 
Pigment
Pigment production was assessed visually after incubation for 2 days at 30°C on glycerol agar.
Statistical methods
Data were analysed for the collection of 469 strains as a whole and also with respect to those serotypes which have significantly different frequencies among clinical and environmental strains [3] . Rough and acapsular strains were also analysed separately in order to assess any involvement of LPS and capsular polysaccharide.
The x2 test and Fisher's exact test were used to determine the statistical significance of associations between serotypes and virulence factors. Yates' correction for non-continuous data was applied to the x2 test, while Fisher's exact test was used when one or more of the expected values was S 0.5. To allow for multiple testing, associations were considered significant for p values at or below 0.01 rather than 0.05.
Results
The results were analysed with respect to serotype and clinical or environmental origin. In addition, as 19% of the clinical strains were from urine, 16% from blood and 14% from the respiratory tract [3] , the data from these strains were analysed with respect to clinical source. However, no significant associations were found and therefore these results are not presented.
Huemagglutinins
Haemagglutination of rabbit, rat, goat and human group 0 rhesus-positive RBC was not found with any of the 469 strains; only one strain agglutinated untreated human group A rhesus positive cells; 20% of strains agglutinated all five of the remaining species, while 42% failed to agglutinate any cells. The only other agglutination patterns seen in > 5% of strains were agglutination of chicken, monkey, guinea-pig and horse RBC (12%) and agglutination of tanned Apositive cells only (8%).
Only one serotype, 0 14:K 14, was significantly associated with haemagglutination (p < 0.0001) ( Table 1) .
When 0 and K serotypes were analysed independently (data not shown), both 0 1 4 and K14 retained the association. In contrast, rough strains showed fewer agglutination reactions than expected (p < 0.01).
Serotype 014:K14 (p < 0.0001) was also associated with MS-HA (indicative of type 1 fimbriae) ( Table 2) . MRK-HA (indicative of type 3 fimbriae) was not associated with any of the serotypes. Separate analysis of serotype showed associations between type 1 and 014, type 1 and K14, and type 3 and 014. Overall, MS-HA was found in 28% of the clinical collection and 17% of the environmental collection (p = 0.16). The corresponding frequencies for MRK-HA were 26% and 11% (p = 0.04).
Extracellular products
Tests for DNAase, lipase and gelatinase were performed as part of the initial identification for all strains [3] , and, therefore, only qualitative and not quantitative results were obtained. Over 99% of the 469 strains were positive for all three enzymes, with four gelatinase-negative strains and two strains negative for either DNAase or lipase. The uniform nature of these results precluded any further analysis. All strains also produced siderophores and haemolysin, while all except one produced lecithinase. The distribution of zone radii for each of these enzymes contained peaks of 3-5 mm (Fig. la-c) . However, a significant proportion of the collection (124/469, 26%) only produced very low levels of haemolysin with zone radii of 0.5 mm. In contrast, 11% of strains were high level siderophore producers with zone radii between 12 and 24 mm, and 30% of strains gave zone radii of 7 mm or more. Over half of the 469 strains (268, 57%) produced sufficient caseinase to generate zones with 11 -13 mm radii (Fig. Id) , although there was a second smaller peak of 27 caseinase-negative strains and 15 strains with a zone of only 0.5 mm radius (9% in total). No significant differences were seen when the clinical and environmental collections were analysed independently. Line plots of zone radius for each serotype separately showed no real significant differences, i.e., peak positions differing by more than the 3 mm variation shown to be the limit of reproducibility. As an example, Fig. 1 shows the percentage frequency distributions of the 014:K14 strains for each enzyme compared with the remainder of the collection.
Serum resistance
Almost half of the strain collection (46%) was hlly serum resistant with only 15% falling in the serumsensitive category. Serum resistance was strongly associated with two serotypes (027:K14 and 06:K14, p < 0.001, Fig. 2 ) in that > 80% of strains of these types were fully serum resistant. The corresponding value for all other serotypes together was 40%. Only rough or acapsular strains were associated with significant levels (40%) of serum sensitivity (p < 0.0001). Strains that were both rough and acapsular (five in all) were invariably serum sensitive.
When the analysis was repeated with separate 0 and K serotypes, the distribution of strains into the three categories of serum resistance was significant for all except 0 8 (p < 0.001 compared with p = 0.18). No significant differences were seen between the clinical (1 5% sensitive, 50% resistant) and environmental collections (1 5% sensitive, 43% resistant). percentages of each collection that were antibiotic resistant. There was virtually no resistance to amikacin, ceftazidime and ciprofloxacin and conversely little sensitivity to ampicillin, cefuroxime, chloramphenicol and tetracycline. However, the difference in tetracycline results was statistically significant (p < 0.01): all 46 environmental strains were resistant to this antibiotic, compared with 84% of clinical strains. For six of the remaining antibiotics, i.e., gentamicin, neomycin, tobramycin, carbenicillin, piperacillin and cefotaxime, < 10% of environmental strains were resistant compared with 24%-41% of the clinical strains. For all except neomycin (p = 0.03), these differences were statistically significant (p < 0.01). The same trend, i.e., a much higher proportion of resistant strains among clinical (56%) than environmental strains (22%) was demonstrable for trimethoprim (p < 0.0001).
Antibiotic resistance
Within the clinical collection, antibiotic resistances were compared between strains from the beginning and end of the 10-year collection period (Table 4b) * MIC values were not available for neomycin because the results were obtained by breakpoint testing.
was true for neomycin and piperacillin, although in these cases the differences were not significant (p > 0.1). No significant differences were seen among the other antibiotics (p>O.2), nor was there any difference in serotype distribution between the two time periods (p > 0.5).
that rough strains and those of serotypes 027:K14 tended to have higher proportions of resistant strains than did other serotypes, while serotypes 06:K14, 08:K14 and 028:K14 were associated with lower than average proportions of resistant strains. This was most obviously the case for gentamicin resistance, but was also found with most of the antibiotics for which sensitivity or resistance was not universal. Within these serotypes, there was no significant difference in resistance with respect to clinical or environmental source. Table 4c shows the antibiotic resistance frequencies with respect to serotype. Associations significant at the 1% level are indicated with *, and those significant at the 5% level with t. The main pattern to emerge was
Serotype 014:K14 did not fall into either group and was associated with higher than average percentages of ampicillin resistance and lower percentages of gentamicin and tetracycline resistance.
Pigment
Overall, 12% of the collection produced the red pigment prodigiosin and this was highly associated with serotype. All strains of serotypes 014:K14 and 027:K14 were non-pigmented. Conversely, 85% of 06:K14 strains, 72% of 08:K14 and 31% of 028:K28 strains were pigmented (p < 0.01). The frequencies of pigmented strains among other serotypes, acapsular and rough strains were 4%, 4% and 18% respectively; none of these serotype groups was significantly associated with pigment production. As would be expected from the differences in serotype distribution, the proportions of pigmented clinical and environmental strains were significantly different (9% and 6 1 % respectively, p < 0.001). However, within each of the three serotypes associated with pigmentation there was no overrepresentation of either clinical or environmental strains, thus there was no serotype-independent association of pigmentation with source.
Discussion
S. marcescens is a typical opportunist pathogen, i.e., one whose normal habitat is the natural environment [ 111 and, therefore, one with which mankind regularly comes into contact. Infections are only produced when either primary or secondary host defences, or both, are severely impaired, as in intensive care patients. Consequently, if the environment is the natural reservoir of hospital strains, the frequencies of epidemiological markers such as serotype should be similar among clinical and environmental strains. Differences in frequency distribution imply that the epidemiological markers are associated in some way with the 'fitness' of the bacteria to produce human infection. This is clearly the case for 5' . marcescens, among which 014:K14 and 027:K14 strains are markedly associated with human disease while 06: K14, 08:K14 and 028:K28 strains are not.
Most studies on the pathogenicity of S. marcescens describe work done on only one or two strains, and many of these papers have been reviewed recently by Hejazi and Falkiner [12] . Two other studies have looked at the virulence factors of a collection of S. marcescens strains. Gaston et al. [13] compared six epidemic neonatal strains with six epidemic adult strains and six sporadic clinical strains, and found associations for haemagglutination and antibiotic resistance, but not for serum sensitivity or survival on human skin. Franczek et al. [14] studied a collection of 122 clinical and 25 environmental strains and found associations for haemagglutination and pigmentation but not for extracellular enzyme production, motility or plasmid carriage. [14] showed MR-HA compared with three-quarters of the environmental strains. These frequencies are higher than those found in the present study, but the differences may be the result of differences in method, particularly bacterial culture conditions, in addition to genuine differences between the strain collections.
Extracellular products do not appear to be important virulence factors for S. marcescens, because there were no significant associations with those serotypes most associated with human disease. However, this may be because the production of the seven enzymes tested for in this study is virtually universal for the species.
Higher proportions of serum-resistant strains were seen for one clinical serotype (027K14) and also one environmental serotype (06:K14), suggesting that this factor is not of major importance in human infection with S. marcescens. This is confirmed by the fact that both rough and acapsular strains showed a negative association with serum resistance, i.e., tended to be serum sensitive, yet neither group occurred at a lower frequency among clinical than environmental strains. A negative association with the absence of LPS and capsular polysaccharide suggests that these polysaccharides play a similar role in S. marcescens as in Escherichia coli. By providing binding sites for C3b, they ensure that any resulting membrane attack complexes are physically distant from the cell wall S. marcescens is intrinsically resistant to ampicillin, cefuroxime and tetracycline [18] and the data for the environmental collection reflect this, although chloramphenicol resistance was also common. However, resistance to aminoglycosides and /I-lactams is clearly more common among clinical strains, as was also found in a Canadian study of 40 isolates from septicaemic patients [ 191. The pattern of acquired resistance is likely to be a reflection of patterns of use, e.g., ceftazidime was introduced in 1983 but has not been widely used except in serious sepsis. Similarly, the introduction of third-generation cephalosporins and quinolones has led to a reduction in the use of aminoglycosides and penicillins, and this may be the explanation for the lower frequencies of resistant strains seen in 1989/1990 compared with 1980. The most striking result from the analysis of the antibiotic resistance data was that all three 'environmental serotypes' were associated with antibiotic sensitivity. Therefore, it is possible that strains of these serotypes are either inherently less antibiotic resistant or alternatively less able to acquire resistance. Such strains would be at a selective disadvantage within the hospital environment and consequently under-represented among the clinical population. However, given that no association was found for 0 1 4 K 1 4 strains, antibiotic resistance is unlikely to be the dominant factor determining a strain's 'fitness' for infection.
It has been known for some time that non-pigmented, antibiotic-resistant strains of S. marcexens are much more common in the clinical setting than in the natural environment and one explanation for this is the fact that acquisition of resistance plasmids by pigmented strains results in higher frequencies of non-pigmented variants [20] . The data presented here show that this is not the whole story; pigmented and non-pigmented clinical strains come from different lineages as indicated by their different serotypes. Pigmentation therefore seems to be a marker of low virulence.
Taken together, the results of this study emphasise the opportunist nature of S. marcescens. This is not an organism which causes primary invasive disease, nor even a specific condition, but rather produces infection when and wherever it gains access to a suitably compromised host. In this context, the increased ability of 014:K14 strains to colonise and infect hospitalised patients compared with other serotypes could be readily explained by a greater ability to adhere to host cells. Further studies are required to investigate adhesion to human cells and tissues, and to ascertain whether the polysaccharide structures that determine serotype are directly involved in adhesion or whether they are merely associated with other adhesins.
